[144] Innoviz Technologies Ltd. SEC Filing

Innoviz Technologies Ltd. (INVZW) submitted a Form 144 disclosing a proposed sale of 4,292 ordinary shares through Oppenheimer & Co. on 09/19/2025 with an aggregate market value of $8,455.24.

Rhea-AI Filing Summary

Innoviz Technologies Ltd. (INVZW) submitted a Form 144 disclosing a proposed sale of 4,292 ordinary shares through Oppenheimer & Co. on 09/19/2025 with an aggregate market value of $8,455.24. The shares were originally acquired on 08/10/2017 under an Employee Stock Option Plan and will be exercised for cash upon exercise. The filer reports total outstanding shares of 169,397,030. The notice also lists a recent sale by the same person of 3,708 shares on 07/24/2025 for $7,450.03. The signer certifies no undisclosed material information.

Insights

Securities Compliance Analyst

TL;DR: Routine Rule 144 filing showing small-scale insider sale; primary implication is regulatory compliance, not material market impact.

The Form 144 discloses a proposed sale of 4,292 ordinary shares, acquired via an employee stock option in 2017, to be sold through a broker on a specified date. Amounts are immaterial relative to the 169.4 million shares outstanding, indicating this is a routine liquidity action rather than a signal of company performance. The filing includes a prior small sale of 3,708 shares within three months, which is consistent with periodic insider monetization. No nonpublic material information is asserted by the signer.

Equity Market Analyst

TL;DR: Insider sale disclosed under Rule 144, but the size is negligible versus outstanding shares; unlikely to affect valuation.

The disclosed aggregate market value (~$8.5k) and share count are trivial compared with the issuer's total share base, suggesting no material dilution or market-moving distribution. The acquisition via an employee option and cash-upon-exercise payment is standard. For investors, the filing confirms transparency around insider transactions but provides no substantive information about operational or financial performance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/22/2025 - 06:24 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001964080
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Innoviz Technologies Ltd.
SEC File Number	001-40310
Address of Issuer	5 URI ARIAV STREET, BLDG. C, NITZBA 300 ROSH HAAIN ISRAEL 4809202
Phone	972 (54) 7260767
Name of Person for Whose Account the Securities are To Be Sold	Cegla Eldar Mordechay
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	4292	8455.24	169397030	09/19/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	08/10/2017	Employee Stock Option Plan	Issuer			4292	09/19/2025	Cash Upon Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Cegla Eldar Mordechay 5 URI ARIAV STREET, BLDG. C, NITZBA 30 Rosh HaAin L3 4809202	Ordinary	07/24/2025	3708	7450.03

144: Remarks and Signature

Remarks	Under a 10b5-1 sale plan adopted on 03/04/2025
Date of Notice	09/19/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/04/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Cegla Eldar Mordechay
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)